Victoria Rashbrook
PhD, MSc, BSc(Hons)
Postdoctoral Research Scientist
I work as a postdoctoral research scientist in the Sparrow group, investigating how of different environmental factors on the development of congenital heart disease and elucidating mechanisms. My background is investigating mechanisms of cardiovascular disease with a view to develop novel therapeutics or preventative measures. In addition to heart development, I have previously worked on atherosclerosis and ischemic disease models.
Recent publications
PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
Journal article
Wood A. et al, (2023), Cardiovasc Res, 119, 599 - 610
Tamoxifen exacerbates morbidity and mortality in male mice receiving medetomidine anaesthesia.
Journal article
Rashbrook VS. et al, (2023), Anim Welf, 32
Cre toxicity in mouse models of cardiovascular physiology and disease.
Journal article
Rashbrook VS. et al, (2022), Nat Cardiovasc Res, 1, 806 - 816
A key role for the novel coronary artery disease gene JCAD in atherosclerosis via shear stress mechanotransduction.
Journal article
Douglas G. et al, (2020), Cardiovasc Res, 116, 1863 - 1874
Tamoxifen-Activated CreERT Impairs Retinal Angiogenesis Independently of Gene Deletion.
Journal article
Brash JT. et al, (2020), Circ Res, 127, 849 - 850